Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (49) clinical trials

NeuroTrials Research is conducting a study to examine the effect of an investigational drug on sleep quality in patients with mild Alzheimer's Disease and cognitive impairment. All study-related care and study drug will be provided at no cost. Qualified participants and caregivers will be compensated for time and travel. Patient ...

Phase

Study Description: CREAD2 is a Phase 3 study investigating the effect of an investigational drug in the form of an infusion on Alzheimer's disease progression in individuals with prodromal to mild Alzheimer's disease. The study drug, crenezumab, is a monoclonal antibody that targets amyloid-beta proteins in the brain. The study ...

Phase

This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline ...

Phase

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease. Study-related exams and study drug are provided at no cost. Qualified participants and caregivers will be compensated for time and travel. Patient Inclusion Criteria: Age 50-89 Diagnosis of probable Alzheimer’s Disease Must have a ...

Phase

Patient Inclusion Criteria: Ages: over 66-85 Male/Female 26 Double Blind Period, Optional 26 week Long Extension No History of Cancer within past 5 years Dementia status of mild to moderate CT or MRI scan within 18 months prior to screening compatible with a diagnosis of probable Alzheimer's disease Score on ...

Phase

This study will evaluate the effects of daily dosing of AC-1204 on cognition, activities of daily living, resource utilization, quality of life, pharmacokinetic measures and safety among participants with mild to moderate Alzheimer's Disease Inclusion Criteria: Dementia status of mild to moderate CT or MRI scan within 18 months prior ...

Phase

EXPEDITION 3 will look at whether the investigational drug solanezumab can help slow the worsening of AD in patients with mild disease. Study duration will be approximately 18 months, followed by an optional open-label extension study. Participants will be randomized in a 1:1 ratio to receive solanezumab or placebo by ...

Phase

Researchers are conducting a local research study for an investigational drug in people with mild Alzheimer's disease.

Phase

52 week duration Lab testing physical exams mental scales PET and MRI scans

Phase

The purpose of this trial is to assess the efficacy and safety of MK-8931 compared with placebo in the treatment of amnestic mild cognitive impairment (aMCI) due to Alzheimer's Disease (AD), also known as prodromal AD. Participants will be randomized to receive placebo, or 12 mg or 40 mg MK-8931, ...

Phase